In vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: application to schizophrenia.

In vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: application to schizophrenia.
复制标题

具有磁共振光谱的神经递质和调节剂的体内评估:对精神分裂症的应用。

DOI:
10.1016/j.neubiorev.2015.01.007
复制
发表时间:
2015-04
影响因子:
8.2
通讯作者:
Rowland, Laura M.
Rowland, Laura M.
中科院分区:
医学1区
文献类型:
--
作者:
Wijtenburg, S. Andrea;Yang, Shaolin;Fischer, Bernard A.;Rowland, Laura M.

文献摘要

参考文献

被引文献

相似文献

现在,先进的质子磁共振波谱(1H-MRS)技术可以在体内测量神经递质和调节剂。本文介绍了磁共振波谱的基本原理,描述了在3 Tesla或更高磁场强度下测量脑谷氨酸、谷氨酰胺、γ-氨基丁酸、谷胱甘肽、N-乙酰基谷氨酸、甘氨酸和丝氨酸的方法,并总结了精神分裂症的神经化学研究结果。总体而言,1H-MRS在产生生物标志物方面具有巨大的前景,这些生物标志物可作为精神分裂症和其他脑部疾病的治疗靶点、预测疾病发作或病情恶化。
In vivo measurement of neurotransmitters and modulators is now feasible with advanced proton magnetic resonance spectroscopy (1H-MRS) techniques. This review provides a basic tutorial of MRS, describes the methods available to measure brain glutamate, glutamine, γ-aminobutyric acid, glutathione, N-acetylaspartylglutamate, glycine, and serine at magnetic field strengths of 3Tesla or higher, and summarizes the neurochemical findings in schizophrenia. Overall, 1H-MRS holds great promise for producing biomarkers that can serve as treatment targets, prediction of disease onset, or illness exacerbation in schizophrenia and other brain diseases.
DOI: 10.1038/mp.2009.121
发表时间: 2010-06
影响因子: 11
作者:
通讯作者: --
DOI: 10.1002/mrm.1910300107
发表时间: 1993-07-01
影响因子: 3.3
作者:
BEHAR, KL;OGINO, T
通讯作者: OGINO, T
DOI: 10.1016/j.schres.2013.02.001
发表时间: 2013-05
影响因子: 4.5
作者:
Ballesteros A;Jiang P;Summerfelt A;Du X;Chiappelli J;O'Donnell P;Kochunov P;Hong LE
通讯作者: Hong LE
DOI: 10.1001/jamapsychiatry.2013.3939
发表时间: 2014-03
期刊: JAMA psychiatry
影响因子: 25.8
作者:
Bustillo JR;Chen H;Jones T;Lemke N;Abbott C;Qualls C;Canive J;Gasparovic C
通讯作者: Gasparovic C
DOI: 10.1002/mrm.1910320304
发表时间: 1994-09-01
影响因子: 3.3
作者:
BEHAR, KL;ROTHMAN, DL;PETROFF, OAC
通讯作者: PETROFF, OAC